| __timestamp | Taro Pharmaceutical Industries Ltd. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 91733000 | 13774000 |
| Thursday, January 1, 2015 | 87644000 | 22479000 |
| Friday, January 1, 2016 | 92365000 | 27388000 |
| Sunday, January 1, 2017 | 85656000 | 35610000 |
| Monday, January 1, 2018 | 88196000 | 49007000 |
| Tuesday, January 1, 2019 | 89971000 | 61139000 |
| Wednesday, January 1, 2020 | 93413000 | 68836000 |
| Friday, January 1, 2021 | 91355000 | 97592000 |
| Saturday, January 1, 2022 | 113676000 | 106903000 |
| Sunday, January 1, 2023 | 198366000 | 120998000 |
| Monday, January 1, 2024 | 218935000 |
Unleashing the power of data
In the ever-evolving pharmaceutical landscape, understanding the financial dynamics of key players is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Vericel Corporation and Taro Pharmaceutical Industries Ltd. over the past decade. From 2014 to 2023, Taro's SG&A expenses have surged by approximately 138%, peaking in 2023. Meanwhile, Vericel's expenses have shown a remarkable increase of around 780% from 2014 to 2023, reflecting its aggressive growth strategy.
These trends highlight the strategic investments both companies are making in their operations, signaling potential growth and market expansion.
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Vericel Corporation
Breaking Down SG&A Expenses: argenx SE vs Vericel Corporation
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Vericel Corporation
Dr. Reddy's Laboratories Limited and Vericel Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Axsome Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
CRISPR Therapeutics AG or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: PTC Therapeutics, Inc. vs Taro Pharmaceutical Industries Ltd. Trends and Insights
Who Optimizes SG&A Costs Better? MorphoSys AG or Taro Pharmaceutical Industries Ltd.
Selling, General, and Administrative Costs: Vericel Corporation vs Dynavax Technologies Corporation
Comparing SG&A Expenses: Vericel Corporation vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Mesoblast Limited vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends